US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist

9.140
-0.030-0.33%

Close Apr 25 16:00 ET

9.140
0.0000.00%

Post 16:20 ET

443.84MMarket Cap-9140P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

11.84%57.42M

19.91%17.57M

26.04%15.69M

24.43%13.75M

-21.06%10.42M

-7.17%51.35M

-1.99%14.65M

-5.63%12.45M

-14.43%11.05M

-7.44%13.2M

Operating revenue

11.84%57.42M

19.91%17.57M

26.04%15.69M

24.43%13.75M

-21.06%10.42M

-7.17%51.35M

-1.99%14.65M

-5.63%12.45M

-14.43%11.05M

-7.44%13.2M

Cost of revenue

Gross profit

Operating expense

-19.20%111.07M

-24.68%24.16M

-8.94%24.45M

-12.80%28.7M

-25.21%34.11M

-54.38%137.46M

-47.50%32.08M

-58.71%26.86M

-57.27%32.92M

-53.53%45.61M

Selling and administrative expenses

-4.89%70.45M

-5.28%15.85M

-4.98%16.14M

7.15%19.28M

-12.61%19.54M

-31.20%74.07M

-44.00%16.73M

-20.24%16.99M

-30.62%17.99M

-26.81%22.36M

Research and development costs

-35.92%40.62M

-45.84%8.31M

-15.77%8.31M

-36.85%9.43M

-37.33%14.57M

-67.27%63.39M

-50.85%15.35M

-77.44%9.87M

-70.79%14.92M

-65.60%23.25M

Operating profit

37.70%-53.65M

62.15%-6.6M

39.18%-8.76M

31.61%-14.95M

26.90%-23.7M

64.99%-86.12M

62.24%-17.43M

72.22%-14.4M

65.89%-21.87M

61.36%-32.42M

Net non-operating interest income expense

210.94%6.77M

-61.41%1.22M

-2.97%1.18M

538.94%1.94M

196.70%2.43M

129.26%2.18M

276.32%3.17M

152.69%1.21M

102.90%303K

79.25%-2.51M

Non-operating interest income

6.68%9.12M

-50.38%1.85M

-35.24%1.79M

2.62%2.5M

--2.98M

670.51%8.55M

1,001.18%3.72M

--2.76M

108.37%2.44M

----

Non-operating interest expense

-63.10%2.35M

13.27%623K

-60.58%609K

-73.42%568K

-78.11%550K

-25.48%6.37M

-74.26%550K

-32.88%1.55M

-81.60%2.14M

-79.25%2.51M

Other net income (expense)

73.11%-2.39M

357K

5.34%-1.17M

74.68%-1.22M

24.67%-8.87M

-59.91%-2.83M

-105.63%-1.24M

-129.05%-4.81M

Special income (charges)

73.11%-2.39M

--357K

--0

5.34%-1.17M

74.68%-1.22M

24.67%-8.87M

--0

-59.91%-2.83M

---1.24M

---4.81M

-Less：Restructuring and merger&acquisition

-59.14%2.39M

---357K

--0

-5.34%1.17M

-74.68%1.22M

-50.42%5.84M

--0

-111.41%-202K

--1.24M

--4.81M

-Less:Other special charges

----

--3.03M

--0

--3.03M

----

Income before tax

46.92%-49.27M

64.82%-5.02M

52.67%-7.58M

37.77%-14.19M

43.42%-22.48M

65.00%-92.82M

75.40%-14.26M

71.35%-16.02M

56.68%-22.8M

49.99%-39.74M

Income tax

65,722.22%5.92M

116,566.67%3.49M

1.37M

29,260.00%1.46M

-175.38%-395K

105.96%9K

98.01%-3K

97.73%-5K

130.84%524K

Net income

-106.33%-55.19M

17.87%-8.51M

-100.98%-8.95M

-91.00%-15.65M

14.87%-22.09M

537.32%872.13M

67.65%-10.36M

2,696.10%916.63M

84.37%-8.19M

67.44%-25.95M

Net income continuous Operations

40.54%-55.19M

40.31%-8.51M

44.14%-8.95M

31.36%-15.65M

45.14%-22.09M

64.98%-92.82M

75.34%-14.26M

71.34%-16.02M

56.51%-22.79M

49.47%-40.26M

Net income discontinuous operations

--0

1,369.96%964.96M

-84.90%3.89M

4,427.01%932.65M

--14.6M

--14.31M

Minority interest income

Net income attributable to the parent company

-106.33%-55.19M

17.87%-8.51M

-100.98%-8.95M

-91.00%-15.65M

14.87%-22.09M

537.32%872.13M

67.65%-10.36M

2,696.10%916.63M

84.37%-8.19M

67.44%-25.95M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-106.33%-55.19M

17.87%-8.51M

-100.98%-8.95M

-91.00%-15.65M

14.87%-22.09M

537.32%872.13M

67.65%-10.36M

2,696.10%916.63M

84.37%-8.19M

67.44%-25.95M

Basic earnings per share

-108.44%-1

-13.33%-0.17

-101.40%-0.17

-154.55%-0.28

-2.94%-0.35

512.89%11.85

65.12%-0.15

2,629.17%12.14

86.25%-0.11

72.58%-0.34

Diluted earnings per share

-108.44%-1

-13.33%-0.17

-101.40%-0.17

-154.55%-0.28

-2.94%-0.35

512.89%11.85

65.12%-0.15

2,629.17%12.14

86.25%-0.11

72.58%-0.34

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	11.84%57.42M	19.91%17.57M	26.04%15.69M	24.43%13.75M	-21.06%10.42M	-7.17%51.35M	-1.99%14.65M	-5.63%12.45M	-14.43%11.05M	-7.44%13.2M
Operating revenue	11.84%57.42M	19.91%17.57M	26.04%15.69M	24.43%13.75M	-21.06%10.42M	-7.17%51.35M	-1.99%14.65M	-5.63%12.45M	-14.43%11.05M	-7.44%13.2M
Cost of revenue
Gross profit
Operating expense	-19.20%111.07M	-24.68%24.16M	-8.94%24.45M	-12.80%28.7M	-25.21%34.11M	-54.38%137.46M	-47.50%32.08M	-58.71%26.86M	-57.27%32.92M	-53.53%45.61M
Selling and administrative expenses	-4.89%70.45M	-5.28%15.85M	-4.98%16.14M	7.15%19.28M	-12.61%19.54M	-31.20%74.07M	-44.00%16.73M	-20.24%16.99M	-30.62%17.99M	-26.81%22.36M
Research and development costs	-35.92%40.62M	-45.84%8.31M	-15.77%8.31M	-36.85%9.43M	-37.33%14.57M	-67.27%63.39M	-50.85%15.35M	-77.44%9.87M	-70.79%14.92M	-65.60%23.25M
Operating profit	37.70%-53.65M	62.15%-6.6M	39.18%-8.76M	31.61%-14.95M	26.90%-23.7M	64.99%-86.12M	62.24%-17.43M	72.22%-14.4M	65.89%-21.87M	61.36%-32.42M
Net non-operating interest income expense	210.94%6.77M	-61.41%1.22M	-2.97%1.18M	538.94%1.94M	196.70%2.43M	129.26%2.18M	276.32%3.17M	152.69%1.21M	102.90%303K	79.25%-2.51M
Non-operating interest income	6.68%9.12M	-50.38%1.85M	-35.24%1.79M	2.62%2.5M	--2.98M	670.51%8.55M	1,001.18%3.72M	--2.76M	108.37%2.44M	----
Non-operating interest expense	-63.10%2.35M	13.27%623K	-60.58%609K	-73.42%568K	-78.11%550K	-25.48%6.37M	-74.26%550K	-32.88%1.55M	-81.60%2.14M	-79.25%2.51M
Other net income (expense)	73.11%-2.39M	357K		5.34%-1.17M	74.68%-1.22M	24.67%-8.87M	0	-59.91%-2.83M	-105.63%-1.24M	-129.05%-4.81M
Special income (charges)	73.11%-2.39M	--357K	--0	5.34%-1.17M	74.68%-1.22M	24.67%-8.87M	--0	-59.91%-2.83M	---1.24M	---4.81M
-Less：Restructuring and merger&acquisition	-59.14%2.39M	---357K	--0	-5.34%1.17M	-74.68%1.22M	-50.42%5.84M	--0	-111.41%-202K	--1.24M	--4.81M
-Less:Other special charges	----	----	----	----	----	--3.03M	--0	--3.03M	----	----
Income before tax	46.92%-49.27M	64.82%-5.02M	52.67%-7.58M	37.77%-14.19M	43.42%-22.48M	65.00%-92.82M	75.40%-14.26M	71.35%-16.02M	56.68%-22.8M	49.99%-39.74M
Income tax	65,722.22%5.92M	116,566.67%3.49M	1.37M	29,260.00%1.46M	-175.38%-395K	105.96%9K	98.01%-3K	0	97.73%-5K	130.84%524K
Net income	-106.33%-55.19M	17.87%-8.51M	-100.98%-8.95M	-91.00%-15.65M	14.87%-22.09M	537.32%872.13M	67.65%-10.36M	2,696.10%916.63M	84.37%-8.19M	67.44%-25.95M
Net income continuous Operations	40.54%-55.19M	40.31%-8.51M	44.14%-8.95M	31.36%-15.65M	45.14%-22.09M	64.98%-92.82M	75.34%-14.26M	71.34%-16.02M	56.51%-22.79M	49.47%-40.26M
Net income discontinuous operations	--0	--0	--0	--0	--0	1,369.96%964.96M	-84.90%3.89M	4,427.01%932.65M	--14.6M	--14.31M
Minority interest income
Net income attributable to the parent company	-106.33%-55.19M	17.87%-8.51M	-100.98%-8.95M	-91.00%-15.65M	14.87%-22.09M	537.32%872.13M	67.65%-10.36M	2,696.10%916.63M	84.37%-8.19M	67.44%-25.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-106.33%-55.19M	17.87%-8.51M	-100.98%-8.95M	-91.00%-15.65M	14.87%-22.09M	537.32%872.13M	67.65%-10.36M	2,696.10%916.63M	84.37%-8.19M	67.44%-25.95M
Basic earnings per share	-108.44%-1	-13.33%-0.17	-101.40%-0.17	-154.55%-0.28	-2.94%-0.35	512.89%11.85	65.12%-0.15	2,629.17%12.14	86.25%-0.11	72.58%-0.34
Diluted earnings per share	-108.44%-1	-13.33%-0.17	-101.40%-0.17	-154.55%-0.28	-2.94%-0.35	512.89%11.85	65.12%-0.15	2,629.17%12.14	86.25%-0.11	72.58%-0.34
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall